Antiretroviral Therapy Outcomes in Malawi: Access, Mortality and Opportunistic Infections

Baxter H K Kachingwe, Li Hsuan Wang, Hui Wen Cheng

Research output: Contribution to journalReview articlepeer-review

2 Citations (Scopus)


Malawi is a sub-Saharan nation with human immunodeficiency virus (HIV) prevalence of 12% and the largest proportion of those infected beings between the ages 15-49 years. In Malawi, HIV is not only a health problem but a socioeconomic one; the impact of which is being felt at family, community and national level. The fight against HIV is led by the National AIDS Commission, mandated to coordinate a multisectorial approach to combat HIV/AIDS. In 2003, the Malawi government launched a program to scale up access to free antiretroviral therapy. Evidence of outcomes of this program has been collected. This article reviews the studies that have looked at the outcomes.

Original languageEnglish
Pages (from-to)235-238
Number of pages4
JournalJournal of Experimental and Clinical Medicine
Issue number4
Publication statusPublished - Aug 2012


  • AIDS
  • Antiretroviral therapy
  • Co-trimoxazole
  • Human immunodeficiency virus
  • Kenya
  • Triomune

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Antiretroviral Therapy Outcomes in Malawi: Access, Mortality and Opportunistic Infections'. Together they form a unique fingerprint.

Cite this